Julie Rubinstein
COO, President at Adaptive Biotechnologies Corp (ADPT)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $15.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 8SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 9,381380,302 held (−2%) | $27.36 | $257K | -3.2% |
| Oct 8SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 1,100379,202 held (−0%) | $28.21 | $31K | -6.1% |
| Oct 8SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 901378,301 held (−0%) | $29.71 | $27K | -10.8% |
| Oct 8SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 499377,802 held (−0%) | $30.53 | $15K | -13.2% |
| Oct 8SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 11,881377,802 held (−3%) | $26.40 | $314K | +0.3% |
| Oct 8SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 11,881377,802 held (−3%) | $25.66 | $305K | +3.2% |
| Oct 5SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 6,081383,602 held (−2%) | $27.57 | $168K | -3.9% |
| Oct 5SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 5,800377,802 held (−2%) | $28.56 | $166K | -7.2% |
| Oct 5SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 11,881377,802 held (−3%) | $28.13 | $334K | -5.8% |
| Oct 5SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 6,699382,984 held (−2%) | $28.82 | $193K | -8.1% |
| Oct 5SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 5,182377,802 held (−1%) | $29.67 | $154K | -10.7% |
| Apr 29SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,037377,802 held (−5%) | $14.23 | $271K | +86.2% |
| Apr 24SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060390,808 held (−5%) | $14.13 | $269K | +87.5% |
| Apr 24SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060386,470 held (−5%) | $13.74 | $262K | +92.8% |
| Apr 24SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060382,132 held (−5%) | $14.02 | $267K | +88.9% |
| Apr 21SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060403,822 held (−5%) | $14.57 | $278K | +81.8% |
| Apr 21SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060399,484 held (−5%) | $14.55 | $277K | +82.1% |
| Apr 21SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 30,941395,146 held (−7%) | $14.66 | $454K | +80.7% |
| Apr 16SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060416,836 held (−4%) | $14.56 | $278K | +81.9% |
| Apr 16SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060412,498 held (−4%) | $14.61 | $278K | +81.3% |
| Apr 16SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060408,160 held (−4%) | $14.18 | $270K | +86.8% |
| Apr 13SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 16,960431,950 held (−4%) | $13.79 | $234K | +92.1% |
| Apr 13SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 2,100429,850 held (−0%) | $14.44 | $30K | +83.4% |
| Apr 13SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 18,660425,912 held (−4%) | $12.75 | $238K | +107.8% |
| Apr 13SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 400425,512 held (−0%) | $13.48 | $5K | +96.5% |
| Apr 13SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 15,722424,512 held (−4%) | $12.95 | $204K | +104.6% |
| Apr 13SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 3,338421,174 held (−1%) | $14.08 | $47K | +88.1% |
| Apr 8SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060442,864 held (−4%) | $14.33 | $273K | +84.9% |
| Apr 8SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060438,526 held (−4%) | $13.56 | $258K | +95.4% |
| Apr 8SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 30,841434,288 held (−7%) | $14.83 | $457K | +78.6% |
| Apr 8SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 100434,188 held (−0%) | $15.48 | $2K | +71.1% |
| Apr 2SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060451,540 held (−4%) | $14.45 | $275K | +83.3% |
| Apr 2SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060447,202 held (−4%) | $14.60 | $278K | +81.4% |
| Mar 31SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 2,738480,876 held (−1%) | $12.49 | $34K | +112.1% |
| Mar 31SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 16,322464,554 held (−3%) | $13.48 | $220K | +96.5% |
| Mar 31SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060460,216 held (−4%) | $12.63 | $241K | +109.7% |
| Mar 31SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060455,878 held (−4%) | $13.45 | $256K | +97.0% |
| Mar 26SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060477,568 held (−4%) | $13.70 | $261K | +93.4% |
| Mar 26SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060473,230 held (−4%) | $14.27 | $272K | +85.6% |
| Mar 26SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060468,892 held (−4%) | $14.12 | $269K | +87.6% |
| Mar 23SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060490,582 held (−4%) | $13.18 | $251K | +101.0% |
| Mar 23SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060486,244 held (−4%) | $13.37 | $255K | +98.1% |
| Mar 23SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060481,906 held (−4%) | $13.83 | $264K | +91.5% |
| Mar 18SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060503,596 held (−4%) | $13.41 | $256K | +97.5% |
| Mar 18SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060499,258 held (−4%) | $13.40 | $255K | +97.7% |
| Mar 18SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060494,920 held (−4%) | $13.18 | $251K | +101.0% |
| Mar 13SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 122,523520,948 held (−19%) | $13.17 | $1.6M | +101.1% |
| Mar 13SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060516,610 held (−4%) | $14.08 | $268K | +88.1% |
| Mar 13SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 13,660517,672 held (−3%) | $12.63 | $173K | +109.7% |
| Mar 13SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 5,400512,272 held (−1%) | $13.43 | $73K | +97.2% |
| Mar 13SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,060507,934 held (−4%) | $12.96 | $247K | +104.4% |
| Mar 10SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 30,941652,147 held (−5%) | $15.14 | $468K | +75.0% |
| Mar 10SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 30,941647,809 held (−5%) | $14.79 | $458K | +79.1% |
| Mar 10SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 19,460643,471 held (−3%) | $14.68 | $286K | +80.4% |
| Mar 5SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 24,423590,429 held (−4%) | $15.49 | $378K | +71.0% |
| Mar 5SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 6,518583,911 held (−1%) | $16.33 | $106K | +62.2% |
| Mar 5SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 30,941579,573 held (−5%) | $16.60 | $514K | +59.6% |
| Mar 5SEC | ADPTAdaptive Biotechnologies Corp | Sell Plan | 30,941575,235 held (−5%) | $16.00 | $495K | +65.6% |
- Sell
COO, President Julie Rubinstein sold $257K of ADPT at $27.36 — pre-scheduled 10b5-1 plan sale.
- Sell
COO, President Julie Rubinstein sold $31K of ADPT at $28.21 — pre-scheduled 10b5-1 plan sale.
- Sell
COO, President Julie Rubinstein sold $27K of ADPT at $29.71 — pre-scheduled 10b5-1 plan sale.
- Sell
COO, President Julie Rubinstein sold $15K of ADPT at $30.53 — pre-scheduled 10b5-1 plan sale.
- Sell
COO, President Julie Rubinstein sold $314K of ADPT at $26.40 — pre-scheduled 10b5-1 plan sale.
- Sell
COO, President Julie Rubinstein sold $305K of ADPT at $25.66 — pre-scheduled 10b5-1 plan sale.